CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2018

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

Study of serum vascular endothelial growth factor versus alpha fetoprotein in hcv cirrhotic patients with hepatocellular carcinoma (HCC) before and after therapeutic intervention

Author: 
Ahmed Samir Abo Halima, Hanan Mahmoud Badawy, Adel Ahmed Mahmoud Youssef, Engy Yousry and Hossam Samir ElBaz
Subject Area: 
Health Sciences
Abstract: 

Introduction: Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers in the world. More than one million cases of HCC occur in the world each year (Jain et al., 2010). Clearly, the available screening methods are inadequate for early detection and follow up of HCC, so there is need for other markers have to high sensitivity in early diagnosis of HCC as well as the specificity in differentiation between HCC and benign lesions (Padma et al., 2009). Human HCC is a highly angiogenic tumor with several studies showing a strong correlation between tissue VEGF levels and HCC (Semela and Dufour, 2004). The aim of the work: •To study the clinical significance of serum VEGF in hepatitis C cirrhotic patients with HCC as a diagnostic marker before intervention and a prognostic marker after intervention to improve the outcome of HCC diagnosis and treatment • To study the VEGF correlation with hepatocellular carcinoma in hepatitis C cirrhotic patients as a simple non invasive tool Patients and Methods: This study was carried on 80 subjects at the Internal Medicine Department of Ain Shams University Hospitals. classified into 3 groups: Group I was 40 patients with hepatocellular carcinoma and liver cirrhosis, subclassified into Group 1A: Included 20 patients with HCC had been subjected to Radiofrequency ablation Group 1B: Included 20 patients with HCC had been subjected to Transarterial chemo-embolization, Group II was 20 patients with liver cirrhosis only without HCC, Group III was 20 healthy subjects served as control group. HCV related liver cirrhosis and HCC diagnosis were confirmed based on clinical, laboratory and radiological data in addition to serum alpha-fetoprotein (AFP) and Measurment of serum vascular endothelial growth factor (VEGF) Results: The sensitivity and specificity of VEGF has been shown to vary with the different cutoff values used. According to these results the sensitivity and specificity of VEGF for selective detection of the HCC group over the cirrhotic group were 97.5% and 95% respectively, at a cut-off value of 118pg/ml In addition, the accuracy of VEGF was 96.7%, similar to that of AFP 96.7%. Conclusion: Plasma VEGF is a sensitive and specific serum marker for the diagnosis of HCC, also VEGF may play a prognostic marker in HCC management.

PDF file: 

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran